Literature DB >> 6983969

Human lymphocyte proliferation. II. Formation of activated (G1) cells.

F Bettens, F Kristensen, C Walker, A L de Weck.   

Abstract

The kinetics of phytohemagglutinin (PHA)-stimulated human peripheral blood lymphocytes in the early phases (G0, G1a, G1b) of the first cell cycle have been analyzed in vitro by cytofluorometry and [3H]thymidine incorporation. Cells were detected in the G1a, G1b and S phases 12-14, 20-22 and 24-26 h after stimulation, respectively. The total number of PHA-induced G1 cells reached a plateau after 32 h of incubation, upon which a second increase followed, 10 h later. The latter increase was considered to be a result of cells initiating their second cell cycle, since it could be abolished by hydroxyurea. By examination of supernatants, interleukin 2 (IL 2) activities could be recovered 6-10 h after PHA stimulation. In contrast, the monokine IL 1 was already detected after 2 h. Both interleukins were present in the culture medium before the major G1a cell formation took place. The titer of free IL 2 increased to a maximum after 18-22 h, whereafter a decline was observed. This decline was less pronounced if cultures were treated with hydroxyurea. Finally, among individual donors, the total number of lymphocytes entering the G1 phase and the time at which the G1a-G1b transition took place varied. Lower numbers of G1 cells and delayed G1a-G1b transition coincided with lower IL 2 titers and delayed occurrence of maximal titers in the supernatants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983969     DOI: 10.1002/eji.1830121110

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 inhibit mitogen-induced human mononuclear cell proliferation.

Authors:  S V Gollapudi; B Vayuvegula; S Gupta; M Fok; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

Review 2.  Lymphocyte proliferation, lymphokine production, and lymphocyte receptors in ageing and various clinical conditions.

Authors:  A L de Weck; F Kristensen; F Joncourt; F Bettens; C Walker; Y Wang
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Influence of macrophage products on the release of plasminogen activator, collagenase, beta-glucuronidase and prostaglandin E2 by articular chondrocytes.

Authors:  V Evêquoz; J Schnyder; U Trechsel; M Baggiolini; H Fleisch
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

4.  Dissociation between interleukin-1 and interleukin-2 production in proliferative response to microbial antigens: restorative effect of exogenous interleukin-2.

Authors:  D Vismara; G Lombardi; E Piccolella; V Colizzi
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

5.  Inhibition of lymphocyte mitogenesis in mice infected with Newcastle disease virus: viral interference with the interleukin system.

Authors:  G Colonna Romano; F Dieli; S Abrignani; A Salerno; V Colizzi
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

6.  Mechanisms by which oxidative injury inhibits the proliferative response of human lymphocytes to PHA. Effect of the thiol compound 2-mercaptoethanol.

Authors:  M A Gougerot-Pocidalo; M Fay; Y Roche; S Chollet-Martin
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.